glp 1 pediatric Two MASLD Publications: Call for Action and Use of GLP-1 RAs GLP-1 medications for weight loss

Last year, FDAacting through the Office of Prescription Drug Promotion (OPDP) within the Center for Drug Evaluation and Research (CDER)issued a high volume of untitled and warning letters as part of a broader push against directtoconsumer (DTC) drug advertising, including 58 letters addressing claims about compounded GLP1s (e.g., semaglutide and tirzepatide) and other compounded products (e.g., sildenafil and tadalafil).[2] By mid2026, activity appeared to taper offraising the question whether FDA had shifted priorities, for example due to personnel changes, or simply paused the effort

Critical Considerations & Current Status Investigational Drug: Cagrilintide is NOT approved for any use

Mitochondrial Biogenesis and Exercise: Lpez-Lluch, G., et al

Patients should consult a qualified healthcare professional and verify current FDA and pharmacy requirements before making treatment decisions.

See Yours

Just do well on the other days and you will still have a great month